Florida, Texas Sue Federal Government, Saying Abortion Drugs Interfere with State Laws
Texas and Florida argue the FDA failed to properly assess mifepristone's safety and effectiveness since 2000, challenging both original and recent generic approvals.
- On Dec 10, Texas Attorney General Ken Paxton and Florida Attorney General James Uthmeier filed a federal lawsuit in Wichita Falls seeking to restrict mifepristone access after FDA approved a new generic, citing case No.7:25-cv-00126.
- Republican attorneys general argue the lawsuit stems from the FDA's failure to re-evaluate mifepristone since 2000 and loosening rules like removing in-person dispensing, alleging arbitrary actions violating the Administrative Procedure Act.
- More than 100 studies show mifepristone is a reliable, low-risk abortion method used in over 60% of U.S. medication abortions, while Evita Solutions supports abortion care access on its website.
- The U.S. Department of Justice will defend the FDA, with appeals going to the 5th U.S. Circuit Court of Appeals; the suit names the U.S. Department of Health and Human Services and agency leaders, arguing federal actions interfere with state abortion laws.
- Last year, the U.S. Supreme Court dismissed a 2022 suit for lack of standing, while Missouri, Kansas and Idaho pursued similar claims, and Health and Human Services Secretary Robert F. Kennedy Jr. delayed a safety report until next year.
13 Articles
13 Articles
Florida, Texas sue federal government, saying abortion drugs interfere with state laws
TALLAHASSEE — Florida and Texas have filed a lawsuit challenging more than two decades of federal-government decisions that cleared the way for the use of abortion drugs — and said the availability of the drugs through the mail has interfered with state laws designed to prevent abortions. The lawsuit, filed Tuesday in federal court in Wichita Falls, Texas, by Florida Attorney General James Uthmeier and Texas Attorney General Ken Paxton alleges t…
GOP AGs in Texas and Florida, citing anti-abortion rhetoric, sue to end abortion pill access
The attorneys general of Florida and Texas are suing the U.S. Food and Drug Administration, challenging access to and federal approval of mifepristone, a drug used to terminate early pregnancies. It’s the third ongoing lawsuit with similar claims filed by Republican state attorneys general more than two years after the U.S. Supreme Court threw out a ruling that would have limited nationwide access to the medication. (Photo by Anna Rose Layden/Ge…
Lawsuit from Texas, Florida AGs takes another crack at limiting abortion pill access
The attorneys general of Florida and Texas are suing the U.S. Food and Drug Administration, challenging access to and federal approval of mifepristone, a drug used to terminate early pregnancies. It’s the third ongoing lawsuit with similar claims filed by Republican state attorneys general more than two years after the U.S. Supreme Court threw out a ruling that would have limited nationwide access to the medication. (Photo by Anna Rose Layden/Ge…
Another Week With Another Abortion Pill Win & Another Abortion Pill Lawsuit
Despite the death of Roe v. Wade in 2022 and the anti-abortion movement’s unrelenting efforts, banning abortion still does not mean people stop needing abortion care. In 2024, 1.14 million abortions were performed in the U.S., and in 2023, the abortion pill mifepristone was used in two-thirds of all abortions. And, this week, a new report and a new lawsuit once again prove why mifepristone is more crucial and more vulnerable than ever. On Tuesda…
Coverage Details
Bias Distribution
- 92% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium








